After Hours Summary: MU +7% rises on earnings/guidance while ALDX -32% falls on results from Phase 3 TRANQUILITY trialAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: MU +6.7%, BRZE +5.9%, NKE +3.7%
Companies trading higher in after hours in reaction to news: ACAD +5.2% (announced plans to resubmit sNDA for NUPLAZID), PSN +4.1% (awarded $38 mln Army task order), FTAI +2.7% (submitted documentation with respect to potential spin-off of infrastructure business), HAYW +2% (approved new $450 mln stock repurchase program), BDSI +1.8% (announced favorable opinion in patent litigation against Alvogen Group), JBL +1.3% (announced new manufacturing partnership with Carnival [CCL]), AMGN +1.3% (announced FDA approval of OTEZLA as treatment for plaque psoriasis)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CVGW -2.7%
Companies trading lower in after hours in reaction to news: ALDX -32% (announced top-line results from Phase 3 TRANQUILITY trial in dry eye disease; primary endpoint of ocular redness was not met), CTMX -19.8% (announced preliminary results from Phase 2 expansion study of CX-2029 in patients with sqNSCLC or HNSCC), DBVT -14.8% (announced plans to initiate new Phase 3 clinical study for modified Viaskin Peanut patch and to withdraw the MAA for Viaskin Peanut in Europe)